+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

U.S. OTC Drugs Market - Industry Outlook & Forecast 2021-2026

  • ID: 5380218
  • Report
  • July 2021
  • Region: United States
  • 180 Pages
  • Arizton
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Abbott
  • American Health
  • Bausch Health Companies
  • Colgate-Palmolive Company
  • Johnson & Johnson
  • Procter & Gamble
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. OTC Drugs Market Report

The U.S. OTC drugs market by revenue is expected to grow at a CAGR of 4.01% during the period 2021-2026.

U.S. OTC DRUGS MARKET: KEY HIGHLIGHTS
  • In 2020, online pharmacies and hospital pharmacies segments accounted for the most significant U.S. OTC drugs market shares of 20.60% and 18.50%, respectively.
  • Based on indication, the infection segment is anticipated to grow with the highest incremental growth of USD 2.78 billion during the forecast period.
  • Online retail giants like Amazon, which recently launched a private label line called Basic Care, contribute to the US OTC drugs market trend.
  • In the past 30 years, the FDA has converted more than 700 prescription (Rx) products to OTC status.
U.S. OTC DRUGS MARKET INSIGHTS

With the rise in self-medication among the US population, the demand for on-the-counter (OTC) drugs are significantly increasing. COVID-19 outbreak has considerably influenced the sales of these drugs with the increased focus on personal health. The expansion in the number of OTC medicines in the region by manufacturing companies and switching prescriptions to OTC drugs highly contributes to market growth. The demand for on-the-counter drugs has constantly been increasing with the rise of private labels, online sales, and the number of OTC product launches in the upcoming years. Recently, the sales of OTC medicines have been growing through online platforms, thereby benefitting private retailers.

MARKET SHARE & SEGMENTS
  • There is a wide and powerful array of OTC, supplemental, and herbal preparations to treat patients with upper and lower GI problems accelerating the market's growth in the US.
  • The demand for cold and cough OTC drugs has already been high, and the dietary supplements are expected to have a higher growth rate mainly due to COVID-19.
  • The increasing population and prevalence of digestive and cardiovascular problems accompanied by a sedentary lifestyle will increase demand for on-the-counter drugs.
  • The online pharmacies distribution channel segment is anticipated to witness an incremental growth of USD 2.90 billion during the forecast period.
  • To reinforce the competitive position, OTC companies may consider acquiring brands rather than companies.
  • The advent of COVID-19 led to an increased dependence on online pharmacies for purchasing medicines fueling the demand for OTC medicines.
Segmentation by Product Type
  • Cold & Cough
  • Analgesics
  • Dietary Supplements
  • Gastrointestinal
  • Dermatology
  • Ophthalmic
  • Others
Segmentation by Indication
  • Infection
  • Pain
  • Heartburn
  • Immune/Health Booster
  • Others
Segmentation by Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Others
COMPETITIVE LANDSCAPE

Leading companies are constantly consolidating their market position through strategic and high-profile mergers and acquisitions. Governments across the US are likely to sponsor campaigns to enhance health education, increasing self-medication. The OTC drugs market in the US is highly competitive and fragmented with the presence of various players. Many leading companies have a broad portfolio of OTC products that the major vendors acquire to strengthen their market value and emerge as the top player in the industry. Vendors are increasingly developing new and more effective products suitable for self-medication to boom in the US OTC drugs market.

Key Company Profiles
  • Johnson & Johnson
  • GlaxoSmithKline
  • Bayer AG
  • Teva Pharmaceutical Industries
Other Prominent Vendors
  • Abbott
  • Achelios
  • Alcon
  • American Health
  • Amway
  • Aytu Consumer Health
  • Bausch Health Companies
  • BioGaia
  • Colgate-Palmolive Company
  • Herbalife Nutrition
  • Perrigo Company
  • Prestige Consumer Health
  • Procter & Gamble
  • Reckitt Benckiser Group
  • Sanofi-Aventis
  • Sun Pharmaceutical Industries
  • The Bountiful Company
  • Viatris
KEY QUESTIONS ANSWERED:

1. What is the market size and forecast for the U.S. OTC drugs industry?
2. What are the different distribution channels for the OTC drugs?
3. Who are the key players in the on-the-counter drugs industry?
4. Which is the leading segment in the US OTC drugs market?
5. What is the impact of COVID-19 on the U.S. OTC drugs market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • American Health
  • Bausch Health Companies
  • Colgate-Palmolive Company
  • Johnson & Johnson
  • Procter & Gamble
1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation by Product Type
4.3.2 Market Segmentation by Indication
4.3.3 Market Segmentation by Distribution Channel

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at A Glance

7 Introduction
7.1 Overview
7.1.1 Launching OTC Drugs in US
7.1.2 Accessibility of OTC Drugs in US
7.1.3 Affordability of OTC Drugs in US
7.1.4 Optimizing OTC Drugs
7.1.5 Trends in Various OTC Therapeutic Categories

8 Market Opportunities & Trends
8.1 Private Labels & Online Sales of OTC Drugs
8.2 Patent Expirations of Prescription Drugs
8.3 OTC Product Launches & Replacement of Prescription Drugs
8.4 Impact of Healthcare Reforms on OTC Drugs

9 Market Growth Enablers
9.1 Growing Trend of Self Medication & Self Care
9.2 OTC Drugs Treating Serious Health Conditions
9.3 Switching of Prescription Drugs to OTC Drugs
9.4 Growing Healthcare Savings by OTC Drugs

10 Market Restraints
10.1 Abuse of OTC Drugs
10.2 Risk of Side Effects by OTC Counter Drugs
10.3 Growing Alternatives to OTC Drugs

11 Market Landscape
11.1 Market Overview
11.1.1 Product Insights
11.1.2 Indication Insights
11.1.3 Distribution Channel Insights
11.2 Market Size & Forecast
11.3 Impact of Covid-19 On the US OTC Drugs Market
11.4 Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Product Type
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Cold & Cough
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Analgesics
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Dietary Supplements
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.6 Gastrointestinal
12.6.1 Market Overview
12.6.2 Market Size & Forecast
12.7 Dermatology
12.7.1 Market Overview
12.7.2 Market Size & Forecast
12.8 Ophthalmic
12.8.1 Market Overview
12.8.2 Market Size & Forecast
12.9 Others
12.9.1 Market Overview
12.9.2 Market Size & Forecast

13 Indication
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Infection
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Pain
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 Heartburn
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.6 Immune/Health Booster
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.7 Others
13.7.1 Market Overview
13.7.2 Market Size & Forecast

14 Distribution Channel
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Retail Pharmacies
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Hospital Pharmacies
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Online Pharmacies
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.6 Others
14.6.1 Market Overview
14.6.2 Market Size & Forecast

15 Competitive Landscape
15.1 Competition Overview
15.2 Market Share Analysis
15.2.1 Johnson & Johnson in OTC Drugs Market in US
15.2.2 GlaxoSmithKline in OTC Drugs Market in US
15.2.3 Bayer AG in OTC Drugs Market in the US
15.2.4 Teva Pharmaceutical Industries in OTC Drugs Market in the US

16 Key Company Profiles
16.1 Johnson & Johnson
16.1.1 Business Overview
16.1.2 Johnson & Johnson in OTC Drugs Market in US
16.1.3 Product Offerings
16.1.4 Key Strategies
16.1.5 Key Strengths
16.1.6 Key Opportunities
16.2 GlaxoSmithKline
16.2.1 Business Overview
16.2.2 GlaxoSmithKline in OTC Drugs Market in US
16.2.3 Product Offerings
16.2.4 Key Strategies
16.2.5 Key Strengths
16.2.6 Key Opportunities
16.3 Bayer AG
16.3.1 Business Overview
16.3.2 Bayer AG in OTC Drugs Market in the US
16.3.3 Product Offerings
16.3.4 Key Strategies
16.3.5 Key Strengths
16.3.6 Key Opportunities
16.4 Teva Pharmaceutical Industries
16.4.1 Business Overview
16.4.2 Teva Pharmaceutical Industries in OTC Drugs Market in US
16.4.3 Product Offerings
16.4.4 Key Strategies
16.4.5 Key Strengths
16.4.6 Key Opportunities

17 Other Prominent Vendors
17.1 Abbott
17.1.1 Business Overview
17.1.2 Product Offerings
17.2 Achelios
17.2.1 Business Overview
17.2.2 Product Offerings
17.3 Alcon
17.3.1 Business Overview
17.3.2 Product Offerings
17.4 American Health
17.4.1 Business Overview
17.4.2 Product Offerings
17.5 Amway
17.5.1 Business Overview
17.5.2 Product Offerings
17.6 Aytu Consumer Health
17.6.1 Business Overview
17.6.2 Product Offerings
17.7 Bausch Health Companies
17.7.1 Business Overview
17.7.2 Product Offerings
17.8 BioGaia
17.8.1 Business Overview
17.8.2 Product Offerings
17.9 Colgate-Palmolive Company
17.9.1 Business Overview
17.9.2 Product Offerings
17.10 Herbalife Nutrition
17.10.1 Business Overview
17.10.2 Product Offerings
17.11 Perrigo Company
17.11.1 Business Overview
17.11.2 Product Offerings
17.12 Prestige Consumer Health
17.12.1 Business Overview
17.12.2 Product Offerings
17.13 Procter & Gamble
17.13.1 Business Overview
17.13.2 Product Offerings
17.14 Reckitt Benckiser Group
17.14.1 Business Overview
17.14.2 Product Offerings
17.15 Sanofi-Aventis
17.15.1 Business Overview
17.15.2 Product Offerings
17.16 Sun Pharmaceutical Industries
17.16.1 Business Overview
17.16.2 Product Offerings
17.17 The Bountiful Company
17.17.1 Business Overview
17.17.2 Product Offerings
17.18 Viatris
17.18.1 Business Overview
17.18.2 Product Offerings

18 Report Summary
18.1 Key Takeaways
18.2 Strategic Recommendations

19 Quantitative Summary
19.1 Market by Product Type
19.2 Market by Indication
19.3 Market by Distribution Channel

20 Appendix
20.1 Abbreviations
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Johnson & Johnson
  • GlaxoSmithKline
  • Bayer AG
  • Teva Pharmaceutical Industries
  • Abbott
  • Achelios
  • Alcon
  • American Health
  • Amway
  • Aytu Consumer Health
  • Bausch Health Companies
  • BioGaia
  • Colgate-Palmolive Company
  • Herbalife Nutrition
  • Perrigo Company
  • Prestige Consumer Health
  • Procter & Gamble
  • Reckitt Benckiser Group
  • Sanofi-Aventis
  • Sun Pharmaceutical Industries
  • The Bountiful Company
  • Viatris
Note: Product cover images may vary from those shown

Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...

Adroll
adroll